Showing 31–33 of 33
bills
All healthcare bills
HB 1382 requires health insurance companies, HMOs, and programs like TennCare to follow specific rules when using artificial intelligence or algorithms to review treatment requests (utilization management). It mandates that AI tools must base decisions on individual patient medical history and provider recommendations - not group data - and cannot override licensed doctors' evaluations of medical necessity. Insurers must disclose AI use in their policies, regularly review AI performance for accuracy, and ensure tools don’t discriminate or harm patients. This bill directly affects all Tennessee health insurance issuers using AI for treatment reviews, including major programs like TennCare and pharmacy benefits managers.
HB 1208 amends Tennessee law to allow pharmacists to provide weight management services through existing collaborative practice agreements with physicians. This change directly affects pharmacists in Tennessee who operate under such agreements and patients seeking weight management support through pharmacy settings. The bill adds "weight management services" to the list of authorized services in these agreements under Tennessee Code Annotated Title 63, Chapter 10. It does not create new requirements but expands current practice options for pharmacists. The bill is currently pending amendment after initial introduction.
SB 436 requires Tennessee's Medicaid program (TennCare) to consider using biosimilar drugs - cost-saving, FDA-approved versions of biologic medications - as part of its drug coverage strategy. It also allows health insurers to require patients to try a biosimilar before covering a branded drug, and directs the state's pharmacy advisory committee to factor biosimilar use into recommendations for the state drug formulary. The bill amends multiple Tennessee Code sections governing drug coverage, pharmacy practices, and formulary decisions. These changes aim to reduce prescription drug costs by expanding the use of biosimilars while maintaining FDA safety and efficacy standards. The bill directly affects TennCare patients, health insurers, and the state's drug formulary decision-making process.
